RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain
Primary Purpose
Facet Joint Arthritis, Pain, Radiofrequency Denervation
Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Radio Frequency Denervation
Local Anesthesia
Sponsored by
About this trial
This is an interventional treatment trial for Facet Joint Arthritis focused on measuring Zygapophyseal Joint
Eligibility Criteria
Inclusion Criteria:
- Patient's age > 25 year
- Signs of degeneration on lateral X-ray
- Cervical facets to be treated between C2 and C7
- Pain for at least 3 months and conservative treatment medication (=paracetamol, Non-Steroidal anti-inflammatory Drugs (NSAID) and/or physical therapy) prior to referral to the pain clinic
- Neck pain on a Numeric Rating Scale ≥ 5
Exclusion Criteria:
- Radiation beyond the shoulder/radicular pain
- Shoulder pain/pathology
- The complaints are directly related to traumatic event e.g. Whiplash (WAD)
- Patient is pregnant, or pregnancy is suspected
- Patient has a cardiac pacemaker, automatic defibrillator or any leads in the neck area
- Allergy to contrast media or drugs to be used in the procedure
- History of anterior fusion at the cervical level to be treated
- Patient is simultaneously participating in another device or drug study related to cervical pain.
- Patient has a spinal fracture, tumor or infection.
- Patient has a central cord lesion in the cervical spine
- Neurologic deficit
- Evidence of disc herniation (extruded, sequestered on MRI imaging)
Sites / Locations
- Maastricht University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
RFD-group
Local Anesthesia-group
Arm Description
Radio Frequency Denervation
Local Anesthesia-group
Outcomes
Primary Outcome Measures
Mean pain intensity measured on a 11-point Numeric Rating Scale (NRS).
Patient Global Impression of Change according to a 7-point Likert scale (PGIC).
Changes in use of pain medication according to the Medication Quantification Scale (MQS).
Changes in the Neck Disability Index scale (NDI).
Secondary Outcome Measures
Changes in quality of life and differences between groups by means of RAND 36.
Improvement in functionality measured by the Patient Specific Functional Scale.
Change in physical/neurological examination parameters.
Change in employment status.
Full Information
NCT ID
NCT01743326
First Posted
November 21, 2012
Last Updated
January 15, 2015
Sponsor
Maastricht University Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT01743326
Brief Title
RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain
Official Title
Percutaneous Radiofrequency Denervation of the Cervical Facet Joints Compared With Cervical Medial Branch Block of the Facet Joints for Patients With Chronic Degenerative Neck Pain : A Prospective Randomized Clinical Study
Study Type
Interventional
2. Study Status
Record Verification Date
January 2015
Overall Recruitment Status
Unknown status
Study Start Date
November 2012 (undefined)
Primary Completion Date
June 2015 (Anticipated)
Study Completion Date
June 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maastricht University Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Rationale: the facet joints are an important pain generator in chronic neck pain. The beneficial effect of radio frequency treatment (RFD) of the cervical facet joints has been described in a Randomized Clinical Trial (RCT) in patients with Whiplash Associated Disorders. In patients with degenerative neck complaints a positive effect has been described in observational studies. Given this positive effect performing a RCT of RFD in this patient population is indicated.
Objective: to evaluate the effect of Radio Frequency treatment in patients with chronic degenerative neck pain.
Study design: prospective, randomized, double blinded clinical trial. Study population: patients older than 25 years, referred to the University Pain Center of Maastricht and the Pain Center of Amphia hospital Breda, with chronic axial neck pain.
Intervention: patients with at least 3 months of neck pain without radiation to the arm (only radiation beyond the shoulder) will be randomized in 2 groups. The first group (RFD + local anesthesia-group=intervention group) will receive RF treatment adjacent to the medial branch innervating the cervical facet joints after the application of bupivacaine 0.5 ml (0.25%). The second group (local anesthesia-group=control group) will only receive the application of 0.5 ml bupivacaine (0.25%) adjacent to the medial branch. The only difference between the two groups is the RF-denervation of the medial branches.
Main study parameters/endpoints: the primary research question is to evaluate the extent of pain reduction induced by RF treatment (RFD + local anesthesia-group=intervention group) compared with the local anesthesia-group(control group.
Following evaluation tools are used : Numeric Rating Scale (NRS), Patient global Impression of Change on a 7 point Likert Scale (PGIC), consumption of pain medication (MQS), Patient Specific Functional Scale, Quality of life scale (RAND 36), Hospital Anxiety and Depression scale (HADS), and Neck Disability Index (NDI, Dutch version).
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients in the RFD + Local Anesthesia-group and Local Anesthesia-group will undergo a physical examination before and 6 weeks after the intervention, by an independent third party, this will be repeated at 3 and 6 months if abnormalities are observed. At each of these time points the patients will receive questionnaires to fill out. A puncture of a blood vessel is possible, diagnosed by injection of contrast, for which repositioning of the needle is needed. Should accidental intravascular injection of local anesthetic occur, the dose used is low and reports show that intravascular injection of bupivacaine 2,5 mg does not pose clinical problems. The dura can be punctured; as a consequence contrast will flow in the cerebrospinal fluid. The procedure will be stopped and repeated after a few days. In theory a lesion of the nerve root is possible, but the needles are designed to avoid this, this complication has not been seen since more than 10 years. Up till now, a transient pain is occasionally described after the RF treatment. No hypesthesia or motor complications were reported. Since the risks of RF treatment are reported low and more related to needle placement there is no difference in risk and burden between the two treatment groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Facet Joint Arthritis, Pain, Radiofrequency Denervation
Keywords
Zygapophyseal Joint
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
84 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
RFD-group
Arm Type
Experimental
Arm Description
Radio Frequency Denervation
Arm Title
Local Anesthesia-group
Arm Type
Active Comparator
Arm Description
Local Anesthesia-group
Intervention Type
Procedure
Intervention Name(s)
Radio Frequency Denervation
Intervention Type
Procedure
Intervention Name(s)
Local Anesthesia
Primary Outcome Measure Information:
Title
Mean pain intensity measured on a 11-point Numeric Rating Scale (NRS).
Time Frame
Baseline, 6 months
Title
Patient Global Impression of Change according to a 7-point Likert scale (PGIC).
Time Frame
Baseline, 6 months
Title
Changes in use of pain medication according to the Medication Quantification Scale (MQS).
Time Frame
Baseline, 6 months
Title
Changes in the Neck Disability Index scale (NDI).
Time Frame
Baseline, 6 months
Secondary Outcome Measure Information:
Title
Changes in quality of life and differences between groups by means of RAND 36.
Time Frame
Baseline, 6 months
Title
Improvement in functionality measured by the Patient Specific Functional Scale.
Time Frame
Baseline, 6 months
Title
Change in physical/neurological examination parameters.
Time Frame
Baseline, 6 months
Title
Change in employment status.
Time Frame
Baseline, 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient's age > 25 year
Signs of degeneration on lateral X-ray
Cervical facets to be treated between C2 and C7
Pain for at least 3 months and conservative treatment medication (=paracetamol, Non-Steroidal anti-inflammatory Drugs (NSAID) and/or physical therapy) prior to referral to the pain clinic
Neck pain on a Numeric Rating Scale ≥ 5
Exclusion Criteria:
Radiation beyond the shoulder/radicular pain
Shoulder pain/pathology
The complaints are directly related to traumatic event e.g. Whiplash (WAD)
Patient is pregnant, or pregnancy is suspected
Patient has a cardiac pacemaker, automatic defibrillator or any leads in the neck area
Allergy to contrast media or drugs to be used in the procedure
History of anterior fusion at the cervical level to be treated
Patient is simultaneously participating in another device or drug study related to cervical pain.
Patient has a spinal fracture, tumor or infection.
Patient has a central cord lesion in the cervical spine
Neurologic deficit
Evidence of disc herniation (extruded, sequestered on MRI imaging)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maarten van Eerd, MD
Phone
+31 43 3875606
Email
mveerd@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Nelleke de Meij, MSc
Phone
+31 43 3872335
Email
p.de.meij@mum.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maarten van Kleef, Prf. MD
Organizational Affiliation
Maastricht University Medical Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maastricht University Medical Center
City
Maastricht
State/Province
Limburg
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maarten van Eerd, MD
Phone
+31 43 3875606
Email
mveerd@gmail.com
First Name & Middle Initial & Last Name & Degree
Nelleke de Meij, MSc
Phone
+31 43 3872335
Email
p.de.meij@mumc.nl
First Name & Middle Initial & Last Name & Degree
Maarten v Kleef, Prf. MD
12. IPD Sharing Statement
Learn more about this trial
RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain
We'll reach out to this number within 24 hrs